Related Experiment Videos
Multiple sclerosis. Sexual dysfunction and its response to medications
D Mattson1, M Petrie, D K Srivastava
1Department of Neurology, University of Rochester (NY) School of Medicine and Dentistry, USA.
Archives of Neurology
|September 1, 1995
Summary
Sexual dysfunction is common in multiple sclerosis (MS) patients, affecting men and women differently. Addressing these issues is crucial for improving patient quality of life.
Area of Science:
- Neurology
- Sexual Medicine
Background:
- Sexual dysfunction is a prevalent and often overlooked issue in multiple sclerosis (MS).
- Understanding the specific nature and frequency of sexual dysfunction in MS is vital for comprehensive patient care.
Purpose of the Study:
- To determine the frequency and characteristics of sexual dysfunction in patients with multiple sclerosis (MS).
- To investigate the response of sexual dysfunction to various treatments, including medications, in MS patients.
Main Methods:
- A retrospective and prospective survey was conducted involving 65 female and 36 male patients diagnosed with MS.
- Data collected included patient-reported sexual activity, interest, specific dysfunctions, and associations with other health conditions.
Main Results:
- 63% of MS patients reported decreased sexual activity, and 35% reported reduced libido. 57 patients experienced sexual dysfunction, with men (78%) more affected than women (45%).
- Common issues included erectile dysfunction and decreased lubrication in men and women, respectively. Both sexes reported reduced sensation and difficulty achieving orgasm.
- Sexual dysfunction correlated with urinary problems and depression history. Corticosteroid treatment unexpectedly improved sexual functioning in some patients.
Conclusions:
- Sexual dysfunction is highly prevalent in multiple sclerosis (MS) and impacts quality of life.
- Identifying and addressing sexual dysfunction as part of MS care is essential.
- Potential treatments, including corticosteroids, may improve sexual functioning in MS patients.